Literature DB >> 29875230

Incidence and clinical characteristics of congenital nasolacrimal duct obstruction.

Saraniya Sathiamoorthi1, Ryan D Frank2, Brian G Mohney3.   

Abstract

BACKGROUND/AIMS: The literature on the prevalence and demographics of congenital nasolacrimal duct obstruction (CNLDO) is 30-70 years old and largely comprises small sample sizes. This study provides epidemiological findings of this common disorder from the largest cohort reported to date.
METHODS: The medical records of all children (<5 years of age) residing in Olmsted County, Minnesota, when diagnosed with CNLDO from 1 January 1995 through 31 December 2004, were reviewed.
RESULTS: Of 17 713 newborns born during the 10-year study period, 1998 were diagnosed with CNLDO, yielding a birth prevalence of one in nine live births. The diagnosis was made in approximately 90% by a primary care physician, at a median age of 5 weeks, with no gender predilection. Compared with the reference population, CNLDO was associated with premature birth (p=0.005) and was more prevalent among Caucasians (p<0.001). Two-thirds of patients initially presented with discharge alone, 18% with tearing alone and 15% with both discharge and tearing.
CONCLUSIONS: In this large population-based cohort, CNLDO occurred in one in nine live births with no gender predilection. Prematurity and Caucasian race were associated with the development of CNLDO. Mucopurulent discharge was a much more common feature than tearing at initial presentation. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Child health (paediatrics); Epidemiology; Lacrimal drainage

Mesh:

Year:  2018        PMID: 29875230      PMCID: PMC7004273          DOI: 10.1136/bjophthalmol-2018-312074

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Congenital impatency of the nasolacrimal duct.

Authors:  D GUERRY; E L KENDIG
Journal:  Arch Ophthal       Date:  1948-02

2.  Developmental anatomy of nasolacrimal duct.

Authors:  J V CASSADY
Journal:  AMA Arch Ophthalmol       Date:  1952-02

3.  The incidence of congenital impotency of the nasolacrimal duct.

Authors:  E L KENDIG; D GUERRY
Journal:  J Pediatr       Date:  1950-02       Impact factor: 4.406

4.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

5.  Congenital nasolacrimal duct obstruction in Japanese infants: its incidence and treatment with massage.

Authors:  S Noda; S Hayasaka; T Setogawa
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1991 Jan-Feb       Impact factor: 1.402

6.  Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.

Authors:  Michael X Repka; Danielle L Chandler; Roy W Beck; Eric R Crouch; Sean Donahue; Jonathan M Holmes; Katherine Lee; Michele Melia; Graham E Quinn; Nick A Sala; Susan Schloff; David I Silbert; David K Wallace
Journal:  Ophthalmology       Date:  2007-11-08       Impact factor: 12.079

7.  Congenital nasolacrimal duct obstruction in premature children.

Authors:  Silvia Helena Tavares Lorena; João Amaro Ferrari Silva; Marinho Jorge Scarpi
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2013-04-30       Impact factor: 1.402

8.  Late and very late initial probing for congenital nasolacrimal duct obstruction: what is the cause of failure?

Authors:  M B Kashkouli; B Beigi; M M Parvaresh; A Kassaee; Z Tabatabaee
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

Review 9.  Management of congenital nasolacrimal duct obstruction.

Authors:  Yasuhiro Takahashi; Hirohiko Kakizaki; Weng O Chan; Dinesh Selva
Journal:  Acta Ophthalmol       Date:  2009-07-21       Impact factor: 3.761

10.  Association between congenital nasolacrimal duct obstruction and delivery by cesarean section.

Authors:  Kristina Spaniol; Tobias Stupp; Carola Melcher; Nadja Beheiri; Nicole Eter; Verena Prokosch
Journal:  Am J Perinatol       Date:  2014-06-27       Impact factor: 1.862

View more
  10 in total

1.  Effect of age on primary balloon dacryocystoplasty and probing success in congenital nasolacrimal duct obstruction.

Authors:  Volkan Dericioğlu; Mehmet Orkun Sevik; Sena Sümmen Saçu; Muhsin Eraslan; Eren Çerman
Journal:  Int Ophthalmol       Date:  2022-05-22       Impact factor: 2.029

2.  Cost comparison of different treatment approaches of dacryocystitis and dacrocystocele.

Authors:  Erin G Sieck; Leonid Zukin; Jennifer L Patnaik; Anne M Lynch; Peggy Kelley; Jasleen K Singh
Journal:  Ther Adv Ophthalmol       Date:  2020-10-09

3.  Age-Specific Outcomes of Conservative Approach and Probing for Congenital Nasolacrimal Duct Obstruction.

Authors:  Apatsa Lekskul; Puncharut Preechaharn; Passara Jongkhajornpong; Wadakarn Wuthisiri
Journal:  Clin Ophthalmol       Date:  2022-06-07

4.  Relative frequencies of ophthalmia neonatorum and congenital nasolacrimal duct obstruction.

Authors:  Thomas Weatherby
Journal:  Br J Gen Pract       Date:  2021-01-28       Impact factor: 5.386

5.  Spontaneous resolution rates in congenital nasolacrimal duct obstruction managed with massage or topical antibiotics compared with observation alone.

Authors:  Brian G Mohney; Saraniya Sathiamoorthi; Ryan D Frank
Journal:  Br J Ophthalmol       Date:  2021-03-17       Impact factor: 5.908

6.  Success rates of probing for congenital nasolacrimal duct obstruction at various ages.

Authors:  Marta Świerczyńska; Ewelina Tobiczyk; Piotr Rodak; Dorota Barchanowska; Erita Filipek
Journal:  BMC Ophthalmol       Date:  2020-10-08       Impact factor: 2.209

7.  Dacryoendoscopy-assisted incision of Hasner's valve under nasoendoscopy for membranous congenital nasolacrimal duct obstruction after probing failure: a retrospective study.

Authors:  Yue Li; Min Wei; Xueru Liu; Leilei Zhang; Xuefei Song; Caiwen Xiao
Journal:  BMC Ophthalmol       Date:  2021-04-19       Impact factor: 2.209

8.  Assessment of Perinatal Clinical Characteristics, Perinatal Risk Factors, and Microbial Profile in Congenital Nasolacrimal Duct Obstruction in a Tertiary Care Center: A Descriptive Study.

Authors:  Kaviyapriya Natarajan; Nirupama Kasturi; Sujatha Sistla
Journal:  Korean J Ophthalmol       Date:  2022-08-05

9.  Factors That Guide the Diagnosis and Treatment Planning for Impacted Canines Using Three-Dimensional Cone-Beam Computed Tomography: A Cross-Sectional Study.

Authors:  Hasan Sabah Hasan; Mohamed A Elkolaly; Ramy Elmoazen; Ayshan Kolemen; Arkan Muslim Al Azzawi
Journal:  Int J Dent       Date:  2022-10-03

10.  Lacrimal sac bacteriology and susceptibility pattern in infants with congenital nasolacrimal duct obstruction in the 1st year of life: a cross-sectional study.

Authors:  Xiao-Yu Zheng; Bonnie Nga Kwan Choy; Ming-Ming Zhou; Cai-Ping Shi; Zheng-Yan Zhao
Journal:  BMC Pediatr       Date:  2020-10-06       Impact factor: 2.125

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.